GKB Ophthalmics re-appoints K.G. Gupta, Cedric Lobo at 44th AGM

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights

GKB Ophthalmics held its 44th AGM on August 25, 2026, in Goa. Shareholders approved FY26 standalone and consolidated financial statements. K.G. Gupta and Cedric Lobo were re-appointed to leadership roles. Management cited global geopolitical tensions and supply chain disruptions as key challenges. The company had 2,602 shareholders as on the record date.

powered bylight_fuzz_icon
49188722

*this image is generated using AI for illustrative purposes only.

GKB Ophthalmics held its 44th Annual General Meeting on August 25, 2026, at its registered office in Mapusa, Goa. The gathering focused on governance continuity and the approval of financial results for FY26.

The meeting commenced at 11:00 am and concluded at 11:25 am. Mr. K.G. Gupta, Chairman & Managing Director, chaired the session. The requisite quorum was present, allowing the proceedings to move forward without delay.

Governance Approvals

Shareholders approved several key resolutions during the meeting. These included the adoption of both standalone and consolidated financial statements for the fiscal year ending March 31, 2026.

The board secured approval for the re-appointment of senior leadership. Mr. Vikram Gupta, who retires by rotation, was re-appointed as a director. Additionally, shareholders passed special resolutions to re-appoint Mr. Cedric Lobo as Executive Director and Mr. K.G. Gupta as Chairman and Managing Director.

Operational Context

In his address, the Chairman highlighted significant global economic uncertainty affecting the manufacturing sector. He cited geopolitical tensions, changing trade policies, volatile raw material prices, and supply chain disruptions as key challenges for FY26.

Despite these headwinds, management emphasized a focus on improving operational performance and strengthening market position. The company aims to create lasting value for stakeholders amidst a complex macroeconomic environment.

Meeting Details

The company provided remote e-voting facilities from August 22 to August 24, 2026. Shareholders who did not vote remotely could cast their votes via poll at the meeting. As on the record date of August 18, 2026, the company had 2,602 shareholders.

Statutory auditors MSKA & Associates LLP, secretarial auditor Ms. Girija Nagvekar, and internal auditors RRK & Co attended the meeting. Mr. Shivaram Bhat served as the scrutinizer for the voting process.

Historical Stock Returns for GKB Ophthalmics

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%-3.08%-3.08%-3.08%-3.08%-3.08%

How does GKB Ophthalmics plan to mitigate the impact of volatile raw material prices and supply chain disruptions on its FY27 margins?

What specific operational strategies has management outlined to strengthen market position amidst the cited geopolitical tensions and changing trade policies?

Are there any new product launches or R&D initiatives announced for the upcoming fiscal year to drive growth despite global economic uncertainty?

GKB Ophthalmics holds 44th AGM on Aug 25 with no dividend

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights

GKB Ophthalmics conducts its 44th AGM on August 25, 2026, in Mapusa, Goa. The company proposes no dividend for FY25-26. Share transfer books close from August 19-25, with e-voting available until August 24.

powered bylight_fuzz_icon
47029430

*this image is generated using AI for illustrative purposes only.

GKB Ophthalmics will hold its 44th Annual General Meeting (AGM) on Tuesday, August 25, 2026, at 11:00 a.m. IST at its registered office in Mapusa, Goa. The company has confirmed that no dividend is proposed for the financial year 2025-26, indicating a strategy to retain capital rather than distribute profits to shareholders during this period. This decision impacts investor returns for the fiscal year ended March 31, 2026.

The Register of Members and Share Transfer Books will remain closed from Wednesday, August 19, 2026, to Tuesday, August 25, 2026, to finalize the list of shareholders eligible for the meeting. Shareholders holding units as of the end of business on Tuesday, August 18, 2026, are entitled to vote. During the closure period, no transfer of shares or registration of new members will be processed.

Key Dates and Details

Event Date
Book Closure Start August 19, 2026
Book Closure End August 25, 2026
44th AGM Date August 25, 2026
Dividend Proposed No

Shareholders can exercise their voting rights through remote e-voting or by attending the AGM in person. The remote e-voting period begins on Saturday, August 22, 2026, at 9:00 a.m. and concludes on Monday, August 24, 2026, at 5:00 p.m. The facility is provided by Central Depository Services (India) Limited (CDSL). Members who have already cast their votes via remote e-voting may attend the meeting but cannot vote again.

Regulatory Compliance and Voting Process

The book closure and AGM proceedings comply with Section 91 of the Companies Act, 2013, and Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notice for the AGM, along with the Annual Report for FY25-26, was dispatched electronically on Friday, July 31, 2026, to members with registered email addresses. For those without registered emails, a letter containing the web-link to the documents was sent.

Mr. Shivaram Bhat, a practicing Company Secretary (Membership No. 10454), has been appointed as the Scrutinizer to oversee the e-voting process. The results of the voting will be declared within 48 hours of the AGM's conclusion. Members holding shares in physical mode are requested to update their KYC details and email addresses with the Registrar and Share Transfer Agent, MUFG Intime India Private Limited, using Form ISR-1 if they have not done so previously.

Historical Stock Returns for GKB Ophthalmics

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%-3.08%-3.08%-3.08%-3.08%-3.08%

What specific capital allocation strategies or growth initiatives is GKB Ophthalmics prioritizing with the retained earnings from FY25-26?

How might the decision to forgo dividends impact GKB Ophthalmics' stock valuation and investor sentiment compared to peers in the ophthalmic sector?

Are there any pending regulatory approvals or strategic partnerships that could influence the company's financial outlook in the upcoming fiscal year?

More News on GKB Ophthalmics

1 Year Returns:-3.08%